AgomAb Therapeutics N.V. American Shares

AGMB | NASDAQ

$7.49

-$0.46 (-5.79%)

At close: Oct 30, 2026, 4:00 PM ET

$7.49

$0.00 (0.00%)

Pre-market: Nov 2, 2026, 8:23 AM ET

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022
PE Ratio	-9.74	-11.23	-42.75	-62.19
PEG Ratio	-6.14	-0.04	-1.05	n/a
PS Ratio	n/a	n/a	n/a	n/a
PB Ratio	4.64	n/a	n/a	n/a
P/FCF Ratio	-11.74	n/a	n/a	n/a
P/OCF Ratio	-11.74	n/a	n/a	n/a
OCF/S Ratio	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0.01	n/a	n/a	n/a
Quick Ratio	6.52	n/a	n/a	n/a
Current Ratio	6.52	n/a	n/a	n/a
Asset Turnover	n/a	n/a	n/a	n/a
Interest Coverage	-987.92	-716.73	-1.01K	-502.98
Return on Equity	-47.78%	n/a	n/a	n/a
Return on Assets	-40.69%	n/a	n/a	n/a
Return on Invested Capital	-43.79%	n/a	n/a	n/a
Dividend Yield	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a